385 related articles for article (PubMed ID: 1383899)
1. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
Zelop C; Nadel A; Frigoletto FD; Pauker S; MacMillan M; Benacerraf BR
Obstet Gynecol; 1992 Oct; 80(4):693-4. PubMed ID: 1383899
[TBL] [Abstract][Full Text] [Related]
2. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
Kupferminc MJ; Tamura RK; Wigton TR; Glassenberg R; Socol ML
Obstet Gynecol; 1993 Aug; 82(2):266-9. PubMed ID: 7687756
[TBL] [Abstract][Full Text] [Related]
3. Unexplained positive/elevated maternal serum alpha-fetoprotein associated with placenta increta. A case report.
McCool RA; Bombard AT; Bartholomew DA; Calhoun BC
J Reprod Med; 1992 Sep; 37(9):826-8. PubMed ID: 1280687
[TBL] [Abstract][Full Text] [Related]
4. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
5. Placenta accreta. A clinicopathologic review of 67 cases.
Morison JE
Obstet Gynecol Annu; 1978; 7():107-23. PubMed ID: 662213
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
Cali G; Forlani F; Giambanco L; Amico ML; Vallone M; Puccio G; Alio L
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():36-41. PubMed ID: 24965977
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study.
Fitzpatrick KE; Sellers S; Spark P; Kurinczuk JJ; Brocklehurst P; Knight M
PLoS One; 2012; 7(12):e52893. PubMed ID: 23300807
[TBL] [Abstract][Full Text] [Related]
8. Placenta percreta: report of a case.
Coates VA; Fishman MS; McCall WG
CRNA; 1999 Nov; 10(4):165-9. PubMed ID: 10723294
[TBL] [Abstract][Full Text] [Related]
9. Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course.
Sumigama S; Itakura A; Ota T; Okada M; Kotani T; Hayakawa H; Yoshida K; Ishikawa K; Hayashi K; Kurauchi O; Yamada S; Nakamura H; Matsusawa K; Sakakibara K; Ito M; Kawai M; Kikkawa F
J Obstet Gynaecol Res; 2007 Oct; 33(5):606-11. PubMed ID: 17845316
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
[TBL] [Abstract][Full Text] [Related]
11. Fraction of cell-free fetal DNA in the maternal serum as a predictor of abnormal placental invasion-a pilot study.
Samuel A; Bonanno C; Oliphant A; Batey A; Wright JD
Prenat Diagn; 2013 Nov; 33(11):1050-3. PubMed ID: 23836321
[TBL] [Abstract][Full Text] [Related]
12. Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa.
Butler EL; Dashe JS; Ramus RM
Obstet Gynecol; 2001 Jan; 97(1):35-8. PubMed ID: 11152903
[TBL] [Abstract][Full Text] [Related]
13. Maternal plasma levels of cell-free β-HCG mRNA as a prenatal diagnostic indicator of placenta accrete.
Zhou J; Li J; Yan P; Ye YH; Peng W; Wang S; Wang XT
Placenta; 2014 Sep; 35(9):691-5. PubMed ID: 25063251
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
Wang N; Shi D; Li N; Qi H
Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
[TBL] [Abstract][Full Text] [Related]
15. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
[TBL] [Abstract][Full Text] [Related]
16. Placenta accreta, increta, and percreta. A survey of 40 cases.
Breen JL; Neubecker R; Gregori CA; Franklin JE
Obstet Gynecol; 1977 Jan; 49(1):43-7. PubMed ID: 299782
[TBL] [Abstract][Full Text] [Related]
17. Midtrimester hemoperitoneum caused by placenta percreta in association with elevated maternal serum alpha-fetoprotein level.
McDuffie RS; Harkness L; McVay RM; Haverkamp AD
Am J Obstet Gynecol; 1994 Aug; 171(2):565-6. PubMed ID: 7520215
[TBL] [Abstract][Full Text] [Related]
18. Antepartum diagnosis of placenta previa percreta by magnetic resonance imaging.
Thorp JM; Councell RB; Sandridge DA; Wiest HH
Obstet Gynecol; 1992 Sep; 80(3 Pt 2):506-8. PubMed ID: 1495723
[TBL] [Abstract][Full Text] [Related]
19. Association of maternal serum alpha-fetoprotein with persistent placenta previa.
Koster EL; Dashe JS; McIntire DD; Ramus RM
J Matern Fetal Neonatal Med; 2004 Jul; 16(1):3-7. PubMed ID: 15370075
[TBL] [Abstract][Full Text] [Related]
20. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta.
Soyer P; Morel O; Fargeaudou Y; Sirol M; Staub F; Boudiaf M; Dahan H; Mebazaa A; Barranger E; le Dref O
Eur J Radiol; 2011 Dec; 80(3):729-35. PubMed ID: 20708361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
